A new retinoid-like compound that activates peroxisome proliferator- activated receptors and lowers blood glucose in diabetic mice

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 7, 2005, Pages 1192-1196

  Deng, Tuo ^a   Shan, Song ^a   Li, Zhi Bin ^a   Wu, Zhong Wen ^a   Liao, Chen Zhong ^a   Ko, Ben ^b   Lu, Xian Ping ^a   Cheng, Jing ^a   Ning, Zhi Qiang ^a  

^a TSINGHUA UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Peroxisome proliferator activated receptor; Retinoid X receptor; Synthetic compound; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; CD36 ANTIGEN; CS 018; ETHYL 7 (2 N PROPOXY 5,5,8,8 TETRAMETHYL 5,6,7,8 TETRAHYDRONAPHTHALEN 3 YL) 6 FLUORO 3 METHYLOCTA 2,4,6 TRIENOATE; FARNESOID X RECEPTOR; GLUCOSE; LIPOPROTEIN LIPASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; DRUG MECHANISM; DRUG SYNTHESIS; GLUCOSE BLOOD LEVEL; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALKENES; ANIMALS; BASE SEQUENCE; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; DIMERIZATION; DNA PRIMERS; MICE; NAPHTHALENES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RETINOIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 24944439456     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.1192     Document Type: Article

References (17)

1. Moller D. E., Nature (London), 414, 821-827 (2001).
2. Desvergne B., Wahli W., Endocr Rev., 20, 649-688 (1999).
3. Duval C., Fruchart J., Staels B., Arch. Mal. Coeur. Vaiss., 97, 665-672 (2004).
4. Gurnell M., Savage D. B., Chatterjee V. K., O'Rahilly S., J. Clin. Endocrinol. Metab., 88, 2412-2421 (2003).
5. Wang Y. X., Lee C. H., Tiep S., Yu R. T., Ham J., Kang H., Evans R. M., Cell, 113, 159-170 (2003).
6. Forman B. M., Umesono K., Chen J., Evans R. M., Cell, 81, 541-550 (1995).
7. Mukherjee R., Davies P. J., Crombie D. L., Bischoff E. D., Cesario R. M., Jow L., Hamann L. G., Boehm M. F., Mondon C. E., Nadzan A. M., Paterniti J. R., Jr., Heyman R. A., Nature (London), 386, 407-410 (1997).
8. Lala D. S., Mukherjee R., Schulman I. G., Koch S. S., Dardashti L. J., Nadzan A. M., Croston G. E., Evans R. M., Heyman R. A., Nature (London), 383, 450-453 (1996).
9. Cesario R. M., Klausing K., Razzaghi H., Crombie D., Rungta D., Heyman R. A., Lala D. S., Mol. Endocrinol., 15, 1360-1369 (2001).
10. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., J. Biol. Chem., 270, 12953-12956 (1995).
11. Feng J., Han J., Pearce S. F., Silverstein R. L., Gotto A. M., Jr., Hajjar D. P., Nicholson A. C., J. Lipid. Res., 41, 688-696 (2000).
12. Schoonjans K., Peinado-Onsurbe J., Lefebvre A. M., Heyman R. A., Briggs M., Deeb S., Staels B., Auwerx J., Embo. J., 15, 5336-5348 (1996).
13. Willson T. M., Brown P. J., Sternbach D. D., Henke B. R., J. Med. Chem., 43, 527-550 (2000).
14. Febbraio M., Abumrad N. A., Hajjar D. P., Sharma K., Cheng W., Pearce S. F. A., Silverstein R. L., J. Biol. Chem., 274, 19055-19062 (1999).
15. Aitman T., Glazier A., Wallace C., Cooper L., Norsworthy P., Wahid F., Nat. Genet., 21, 76-83 (1999).
16. Havel R., Gordon R.S. J., J. Clin. Invest., 39, 1777-1790 (1960).
17. Heizmann C., Kirchgessner T., Kwiterovich P., Ladias J., Derby C., Antonarakis S., Lusis A., Hum. Genet., 86, 578-584 (1991).